Skip to main content
Enter your keywords
User account menu
Log in
Main navigation
About
History & Impact
Mission & Values
Leadership
Support SWOG
Join SWOG
Policies & Procedures
Careers
Contact Us
The SWOG Network
How We Work
Our Staff
Our Advocates
Our Partners
News & Events
News
SWOG Meetings
For Press
Clinical Trials
Biospecimen Submission
Biospecimen Access
Data Requests
Clinical Trials Search
Clinical Research Resources
Frequently Asked Questions
Publications
Institutions
Quality Assurance & Audits
Serious Adverse Events
Training Resources
ORP (CRA) Workbench
Protocol Workbench
Workbenches
ORP (CRA) Workbench
Protocol Workbench
VA Workbench
For Patients
Patient & Advocate Voices
Trials Open to Patients
About SWOG Cancer Trials
Joining a Trial
Section navigation
Recent Updates
12/1/2025
11/15/2025
11/1/2025
10/15/2025
10/1/2025
9/15/2025
9/1/2025
8/15/2025
8/1/2025
7/15/2025
7/1/2025
6/15/2025
All Updates
Breadcrumb
SWOG
Member Resources
Trial & Business Updates
comboMATCH
Priority List comboMATCH
EAY191-S3
II
Phase 2 Study of Paclitaxel + Ipatasertib in Taxane-Refractory Patients with AKT-Altered Advanced Non-Breast Solid Tumors
